Investigating the expression of CTLA-4 and CD28 genes as immune regulators in patients with colorectal polyps
Authors:
Open Access
- 3 June 2026
- journal article
- Published by Springer Nature in BMC Cancer
- Vol. 26 (1)
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Decoding hepatocarcinogenesis from a noncoding RNAs perspectiveJournal of Cellular Physiology, 2023
- Long noncoding RNA HAGLR sponges miR‐338‐3p to promote 5‐Fu resistance in gastric cancer through targeting the LDHA‐glycolysis pathwayCell Biology International, 2021
- Investigation of the relationship between CTLA4 and the tumor suppressor RASSF1A and the possible mediating role of STAT4 in a cohort of Egyptian patients infected with hepatitis C virus with and without hepatocellular carcinomaArchives of Virology, 2021
- Prognostic impacts of tumoral expression and serum levels of PD-L1 and CTLA-4 in colorectal cancer patientsCancer Immunology, Immunotherapy, 2020
- Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancerCancer Immunology, Immunotherapy, 2020
- Co-signal Molecules in T Cell Activation2019
- Elevated Proinflammatory Cytokine IL-17A in the Adjacent Tissues Along the Adenoma-Carcinoma SequencePathology and Oncology Research, 2014
- Peripheral blood gene expression of B7 and CD28 family members associated with tumor progression and microscopic lymphovascular invasion in colon cancer patientsJournal of Cancer Research and Clinical Oncology, 2010
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Tumor-infiltrating lymphocytes: their phenotype, functions and clinical useCancer Immunology, Immunotherapy, 1994